Uriviga M 25 Tablet contains Tamsulosin 0.4mg + Mirabegron 25mg, a dual-action therapy for urinary tract management, including bladder outlet obstruction and overactive bladder. Tamsulosin relaxes smooth muscles of the urinary tract to improve urine flow, while Mirabegron reduces bladder overactivity, ensuring comprehensive symptom control and improved patient comfort.
The combination is well-regarded by prescribers due to its efficacy, tolerability, and patient-friendly dosing, generating consistent demand. Patients benefit from enhanced urinary function, reduced urgency and frequency, and better adherence to treatment.
For franchise partners, Uriviga M 25 Tablet is a high-demand urology product with strong market potential. Its proven clinical performance and prescriber confidence make it a profitable addition to urology portfolios, supporting business growth and long-term customer retention.
With its dual benefit of urinary relief and bladder health support, Uriviga M 25 Tablet offers sustainable sales opportunities, making it an excellent choice for partners serving the urology and urinary care segment.
Common side effects may include dizziness, headache, dry mouth, constipation, palpitations, and mild gastrointestinal discomfort. Some patients may experience elevated blood pressure, blurred vision, or urinary retention. Any severe or persistent symptoms should be reported immediately to a healthcare professional.
Uriviga M 25 Tablet is indicated for the treatment of overactive bladder with symptoms such as urinary urgency, frequency, nocturia, and urge incontinence. It is also useful for patients with bladder outlet obstruction due to benign prostatic hyperplasia who require combination therapy but may benefit from a lower dose of Mirabegron.
Uriviga M 25 Tablet should be taken exactly as prescribed by a healthcare professional. Caution is advised in patients with severe kidney or liver impairment, uncontrolled hypertension, or urinary retention. Do not exceed the recommended dose, and inform your doctor about other medications or medical conditions before use.
Store Uriviga M 25 Tablet in a cool, dry place below 25°C, protected from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date indicated on the pack.